Request for Opioid Escalation in a Patient With Sleep Apnea and Benzodiazepine Use
54-year-old woman with 3 years of chronic axial low back pain. She takes oxycodone 10 mg every 6 hours (40 mg/day) and clonazepam 1 mg at bedtime. She has depression, obesity, and untreated obstructive sleep apnea (apnea–hypopnea index 32; CPAP was prescribed but she does not use it). Pain is 8/10 and she requests oxycodone 20 mg every 6 hours. She has no history of early refills or lost prescriptions. Examination shows diffuse paraspinal tenderness and pain-limited range of motion. She reports daytime somnolence and has had one near-miss motor vehicle crash. The state prescription database shows only her prescribers.
1. How would you assess her risk and respond to the request for a dose increase?
Read the worked answer
Her risk is high: concurrent benzodiazepine and opioid, untreated moderate-severe OSA, depression, daytime somnolence, and a near-miss crash. A dose increase would worsen respiratory depression and cognitive impairment. The absence of aberrant refills is reassuring but does not offset physiologic risk. I would not increase the opioid. I would review the PDMP, obtain a urine drug screen, and screen for depression and suicide risk. The clonazepam should be discussed with her prescriber for a gradual taper, and she should be restarted on CPAP with sleep medicine follow-up. If opioids continue, use the lowest effective dose, avoid concurrent sedatives, and document a single-prescriber agreement and naloxone provision.
2. Outline a taper and alternative pain plan, including safety monitoring.
Read the worked answer
Do not stop abruptly. Reduce the oxycodone by about 10% per month, or slower if withdrawal is severe, while coordinating with the benzodiazepine prescriber for a separate slow taper. Offer buprenorphine as an alternative only if she meets criteria and after considering her benzodiazepine use; it may reduce overdose risk but requires careful induction. Add nonpharmacologic care: physical therapy with graded activity, CBT for pain and insomnia, weight management, and CPAP. For analgesia, use acetaminophen and topical agents; avoid systemic NSAIDs if she has metabolic syndrome or CKD. Enlist an addiction medicine or pain psychologist. Monitor somnolence, respiratory symptoms, mood, and function. Provide naloxone and counsel her not to drive when sedated.
3. What outcomes would you use to judge success, and what would make you refer her to a higher level of care?
Read the worked answer
Judge success by function and safety, not just pain scores: CPAP adherence, Epworth Sleepiness Scale, driving safety, physical function, sleep continuity, mood, and absence of overdose or aberrant behavior. A 30% improvement in function or stable function with a lower opioid dose is meaningful. Refer to addiction medicine or a multidisciplinary pain program if she shows escalating use, uses nonprescribed sedatives, has suicidal ideation, or cannot taper despite support. Urgent referral is needed for respiratory depression, overdose, or severe withdrawal. Document the rationale for not escalating and the shared safety plan.